-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Xenon Pharmaceuticals, Lowers Price Target to $78

Benzinga·05/08/2026 11:36:13
Listen to the news
Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and lowers the price target from $80 to $78.